| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851491 | American Journal of Kidney Diseases | 2007 | 9 Pages |
Abstract
A 12-month course of MMF decreased proteinuria and improved renal function in the majority of patients, but did not appear as effective or better tolerated than cyclophosphamide. Long-term data and randomized controlled trials are needed to ascertain the efficacy of MMF in patients with idiopathic membranous nephropathy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Amanda J. MD, PhD, Peggy W. MD, PhD, Marc MD, Jack F. MD, PhD,